CASP8 and non-Hodgkin lymphoma: Numerous studies investigated whether variation in the CASP8 [27, 28] gene region alters cancer risk, including cancers of lung [29], breast [30], pancreas [31], non-Hodgkin lymphoma [32], head and neck [3].